Genetic deletion of eNOS and pharmacological inhibition of its activity reduces peritumoral lymphatic hyperplasia in VEGF-C-overexpressing fibrosarcoma and attenuates trafficking of tumor cells to draining LNs, suggesting the role of NO in regulating lymphatic drainage [66]. This evidence concerns the gene VEGFC and neoplasm.